Nicholas Breitborde, PhD
Associate Professor-Clinical Early Psychosis Intervention Center (EPICENTER)
Departments of Psychiatry & Behavioral Health and Psychology, The Ohio State University
Dr. Nicholas Breitborde is an Associate Professor in the Department of Psychiatry and Behavioral Health at The Ohio State University and Director of the OSU Early Psychosis Intervention Center (OSU EPICENTER). He received his Ph.D. from the University of California, Los Angeles and completed his clinical internship and postdoctoral training at Yale University. To date, his research has been cited over 6,000 times and has been funded by the National Institute for Mental Health, the Institute for Mental Health Research, and the Ohio Department of Health.
Dr. Breitborde served as an expert international consultant for the University of Calgary consensus process for identifying the critical elements of care for individuals with first-episode psychosis. Currently, he serves as a Content Area Expert in Schizophrenia, Major Depressive Disorder, Bipolar Affective Disorder, and All-Cause Mortality for the Global Burden of Disease Study. He is a member of the American Psychological Association Task Force on Serious Mental Illness and Severe Emotional Disturbances and a founding member of the Prodrome and Early Psychosis Program Network (PEPPNET) Treatment Workgroup—a national committee designed to provide ongoing evaluation and review of evidence-based treatment components for individuals at clinical high risk for and experiencing first-episode psychosis.
Presentation: Coordinated Specialty Care and Beyond for Individuals with First-Episode Psychosis
Growing evidence suggests that targeted interventions provided early in the course of a psychotic disorder may have a disproportionately positive effect in ameliorating the morbidity and mortality associated with these disorders. These data have sparked a growing national effort in developing and disseminating specialized care programs for individuals with first-episode psychosis (i.e., Coordinated Specialty Care: CSC) throughout the United States. In this presentation, I will review data highlighting the clinical effectiveness and cost-savings associated with this treatment approach for first-episode psychosis and discuss and review effort to further improve clinical services for individuals with first-episode psychosis.
Following this presentation, participants will be able to:
• Define the ‘critical period hypothesis’ with regard to early intervention for psychosis
• Identify the components of care encompassed within the Coordinated Specialty Care model for first-episode psychosis